There is a need for safe and broadly effective anti-HCV agents that can cope with genetic multiplicity and mutations of the virus. immune response (and production of designed antibodies in a variety of types including intact IgG and antibody fragments, without a long term immunization process and immune regulations and they can be readily standardized.… Continue reading There is a need for safe and broadly effective anti-HCV agents